Fenbendazole Cancer Clinical Trials

1 / 30

2 / 30

3 / 30

4 / 30

5 / 30

6 / 30

7 / 30

8 / 30

9 / 30

10 / 30

11 / 30

12 / 30

13 / 30

14 / 30

15 / 30

16 / 30

17 / 30

18 / 30

19 / 30

20 / 30

21 / 30

22 / 30

23 / 30

24 / 30

25 / 30

26 / 30

27 / 30

28 / 30

29 / 30

30 / 30

❮ ❯

Aug 9, 2018 · in this study, we show that fenbendazole (fz) exhibits a moderate microtubule depolymerizing activity towards human cancer cells, but possesses a potent antitumor effect.